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Attention Deficit Disorder: An Overview
Wiley C. Rasbury, PhD*

here have always been and probably always will be children
who are hyperactive, impulsive, inattentive, and distractible. One of the first descriptions of such children was given by
Dr George Still (1) in 1902 in his lecture to the Royal Academy
of Physicians in London. In the past 80 years interest in the
study of children with these behavior characteristics has grown
with respect to the etiology, management, and outcome of their
condition.
More literature has been published on the group of behaviors
now referred to as the attention deficit disorder (ADD) than on
any other psychosocial problem in childhood. Approximately
31 publications were written on the ADD between 1957 and
1960, 2,000 between 1961 and 1976, 700 from 1977 to 1980 (2),
and over 900 from 1981 through 1987. However, the.se statistics
do not necessarily imply that the incidence of ADD is rising, and
it is still impossible to make concrete epidemiological statements given the lack of agreement on a definition of the condition. However, substantial evidence shows that some children
are significantiy less atientive and more impulsive, distractible,
and/or hyperactive than their peers and that such problems can
interfere with their social, personal, and academic adjustment.
No precise definition of the ADD exists, and we do not know
whether or not such childhood behavioral problems are more
common today than in the past. Neither do we know exactly
what causes such behaviors, nor how to best manage and/or treat
these children, although Ross and Ross (2) and Weiss and
Hechtman (3) have addressed these issues.

T

Definitions
While there is some consensus on the behaviors of this disorder, ambiguity still exists. As Conners and Wells (4) noted:
"The symptoms appear to come from the same pot, but are
sometimes stirred a bit differently. The range of symptoms involved seems for the most part to reflect a difference in emphasis
rather than fundamental disagreement." In his review of over
200 studies on the ADD, Barkley (5) found that over 70% failed
to use any objective or specifiable criteria for diagnosis. The
definition by the American Psychiatric Association (APA) (6) is
based on a specific set of behaviors which includes most of those
ofconcem to researchers and clinicians (Table I). Unfortunately,
the APA definition, like most, lacks specificity regarding
etiology, intensity of symptoms, pervasiveness, and numerous
aspects of differential diagnosis and fails to clarify the definitional picture of the disorder In clinical practice no universally
agreed upon approach to diagnosis exists, but presumably most
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clinicians rely on their experience with children to render a diagnosis based on age of onset of symptoms, intensity, pervasiveness, duration of specific behaviors, and exclusion of
other psychopathological and nonpsychopathological childhood
conditions that can cause such behaviors. While clinicians use a
variety of methods to diagnose this disorder, generally the following criteria are useful: 1) history; 2) behavioral ratings on
standardized forms completed by parents and teachers; 3)
clinical observations; and 4) psychological test performance, especially on tasks of attention/concentration and leaming (7). In
the final analysis, an adequate or acceptable definition of the
ADD will evolve slowly with continuing research. The operational definition offered by the APA, while not wholly acceptable, does attempt to reflect knowledge gained from research in
this area and therefore may be considered as an acceptable operational guideline subject to ongoing refinement.

Prevalence
Prevalence estimates of the ADD vary from 1% to 10% with an
average of 5%; estimates are significantiy lower (typically 1% to
1.5%) when diagnosis is based on agreement of multiple sources
such as teachers, parents, physicians, or other clinicians (8).
Male:female estimates have ranged from 3:1 to 9:1, with a mean
of 6:1. Cross-cultural studies utilizing teacher ratings alone have
revealed estimates of 12% to 18% (8). These higher estimates,
assuming they are valid, probably represent a heterogeneous
group of children with respect to the factors causing their behavior, with a much smaller subset meeting a morerigorousdefinition of the disorder Also, such data reflect the potential danger
in basing a diagnosis of ADD solely on teacher ratings, especially if medication is recommended as the primary treatment
approach. Of the children referred to our clinic, 50% to 60%
have teacher ratings suggesting the ADD, but no more than 2%
to 3% of these children receive the diagnosis.

Etiologic Speculations
Lack of etiologic knowledge before the 1970s has been noted
in various reviews (9), but much progress has been made in the
last decade in identifying possible causes ofthis disorder While
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views have shifted away from unifactorial to multifactorial
causes, no proposed explanation for the condition has been universally or even consensually accepted by researchers and clinicians. Furthermore, a number of thought-provoking articles
have questioned the utility and validity of the attention deficit
concept (10,11). Various areas implicated as possible explanations for the ADD, ranging from central nervous system damage
to child-rearing practices, are discussed in the following
sections.
Central nervous system daniage
While injury or infection of the central nervous system can
produce either a transient or chronic ADD, such damage accounts for no more than 5% of the children viewed as manifesting these behaviors. Numerous studies of children diagnosed
with the disorder report that approximately 50% had "soft" neurological signs, but the etiologic relevance of these signs has
been questioned. As Touwen and Sporrel (12) stated: "The attempt to explain disorders of complex behavior only on the basis
of neurological minor signs testifies to an objectionable kind of
reductionism."
Neuroanatomic
Recent reviews (13,14) revealed no less than 11 different (in
some cases overlapping) theories of the neuroanatomic basis of
the disorder While none of these have gained significant empirical support, the most intriguing theories postulate a relationship between various subcortical brain structures and the
frontal lobes.
Neurotransmitter
Much interest has been placed on the role of dopamine and, to
a lesser extent, of norepinephrine on the mediation of the ADD.
Interest in these sympathomimetic amines largely stems from
use of the stimulants methylphenidate hydrochloride, dextroamphetamine sulfate, and pemoline which affect the release
and reuptake of dopamine and norepinephrine (15) and help to
reduce attention deficit behaviors. Several reviews have been
published on the role of neurotransmitters in this condition
(13,14,16,17). Zametkin and Rapoport (13,14) attempted to integrate neuroanatomic and neurotransmitter theories of attention
deficit behavior. In general, as with neuroanatomic theories,
there is no singulariy accepted biochemical theory of the disorder. Furthermore, given the status of this research, it is inappropriate for clinicians to tell parents or the affected child that
the attention deficit behavior is the result of a "chemical imbalance." Such statements are at best misleading and at worst
counterproductive in the management of these patients.
Genetic
Genetic studies of families and adoptees provide some support for the possible genetic transmission of the ADD, but the
research lacks sufficient scientific evidence (2). Researchers
suspect that if the disorder is transmitted genetically, it is polygenetic in nature. One of the more interesting theories of genetic
transmission suggests that the disorder is part of a broader
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Table 1
Diagnostic Criteria for the Attention Deficit Disorder*
Inattention (at least three ofthe following):t
Fails to finish what is started
Fails to listen
Easily distracted
Difficulty concentrating on schoolwork or other tasks requiring sustained
attention
Difficulty remaining with a play activity
Impulsivity (at least three of the following):!
Acts before thinking
Difficulty organizing work (not due to cognitive impairment)
Needs much supervision
Frequently calls out in class
Difficulty awaiting tura in games or group simations
Hyperactivity (at least two of the following):!
Runs about or climbs excessively
Difficulty sitting still or fidgets excessively
Difficulty staying seated
Moves about excessively during sleep
Always "on the go" or acts as i f "driven by a motor"
Onset before age 7
Duration at least six months
Not due to schizophrenia, affective disorder, or severe or profound mental
retardation
*From American Psychiatric Associalion. Diagnostic and statistical manual of mental
dfsorders. 3rd ed. Washinglon. DC: American Psychiatric Associalion. 1980.
tThe number of symptoms specilied is for children between ages 8 and 10. the peak age
range for referral. In younger children, more severe forms of the symptoms and a greater
number of symptoms are usually present. The opposile is true in older children.

constellation of disinhibitory conditions (eg, alcoholism, psychopathy, hysteria, antisocial behavior, and impulsive personality) (18).
Constitutional
Thomas and Chess (19,20) suggested infant temperament as a
possible cause of attention deficit behavior The numerous temperament styles delineated are assumed to reflect normal genetic
variation in the expression of behavior. Theoretically, the behaviors delineating the ADD are reflective of constitutionally-based
temperament patterns. The absence ofany convincing pathophysiologic process in most children with the disorder makes
the study of temperament pattems particularly interesting. Unfortunately, the methodological problems inherent in the study
of temperament make it difficult, if not impossible, to make
conclusive etiologic statements.
Food additives
In the 1970s, food additives were proposed as a major cause of
the ADD in children. Conners (21) cast significant doubt on the
validity of food additives as a relevant etiologic factor At best,
an extremely small percentage of children (3% or less) may
manifest attention deficit behaviors secondary to problems with
the metabolism of food additives. During the 1980s, studies
were conducted on the role of sugar as a cause of these behaviors, but the results do not support such a relationship. Allergies,
particularly food allergies, also have been suggested as a cause,
but no convincing evidence has been reported (22).
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Child-rearing patterns
Child-rearing approaches have been implicated as a cause of
attention deficit behaviors, as well as parents who serve as potential primary role models for the imitation of such behaviors
(2). Whether such experiences are sufficient to produce the
ADD is unknown.
Social and emotional adjustment problems
Most clinicians realize that attention deficit behaviors can be
present in children with primary emotional disturbances, acute
stress, and/or conflict and tension within the family. However, it
is unclear whether such problems can, by themselves, produce a
child with the disorder Attention deficit behaviors secondary to
these psychosocial problems can lead to an erroneous diagnosis
of the ADD and inappropriate management of the child's
problems.
Academic failure and frustration
While attention deficit behaviors can interfere with optimal
school performance, primary leaming problems may also give
rise to emotional lability, fmstration, reduced motivation, and
subsequently to attention deficit behaviors (5). In my opinion,
many children with learning difficulties are misdiagnosed as
having the ADD.

TVeatment
Medication
Despite recent controversy over the use of stimulants in children with the ADD (23), stimulant medication is the most common treatment approach and probably the most effective as a
symptom-suppression agent. Yet positive response to stimulant
medication is not a confirmation of the diagnosis. Studies show
that approximately seven of ten children, adolescents, or adults
who are given stimulants will show improvement of the target
behaviors for which stimulant medication is administered (ie,
hyperactivity, inattention, distractibility, and impulsivity)
(22,24). Beyond this base-rate responsiveness to stimulant medication, no single or multiple predictors can gauge responsiveness to stimulants. It was formerly thought that attention
deficit behavior secondary to central nervous system damage
could be reduced more effectively with antipsychotic medications than with stimulants, but no convincing evidence has
been presented. Nor is there evidence that the use of stimulants
etiminates (ie, cures the child of) attention deficit behaviors.
Stimulants cannot teach the child how to behave in a socially,
interpersonally, or academically adaptive manner, even though
they may facilitate improved functioning in these areas. These
types of skills must be leamed.
The most commonly used stimulants are methylphenidate hydrochloride, dextroamphetamine sulfate, and pemoline. Methylphenidate hydrochloride and dextroamphetamine sulfate are
essentially equal in their overall effectiveness and reported side
effects, although dextroamphetamine sulfate is thought to suppress appetite more than methylphenidate hydrochloride.
Pemoline is less effective than the other two but has similar side
effects. Other psychotropic medications have been used, notably antipsychotics and antidepressants, but with less success
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(14,25). Methylphenidate hydrochloride (5, 10, and 20 mg) and
dextroamphetamine sulfate (5 mg) tablets are relatively quick
acting (within 30 to 40 minutes) and of short duration (three to
four hours). Methylphenidate hydrochloride also is available as
atime-releasepreparation (20 mg slow release) which is effective for approximately eight hours, while the dextroamphetamine sulfate time-release preparation (5, 10, and 15 mg) is
effective for approximately 12 hours. Pemoline (18.75, 37.50,
and 75 mg) is administered once daily but requires two to three
weeks of continuous administration before a therapeutic effect is
noted. The development of tolerance to stimulant medication is
rare (25). Preschool children (aged 3 to 5 years) need higher
doses per kilogram of body weight than elementary school children (aged 6 to 12 years), and adolescents need lower doses per
kilogram of body weight than elementary school children. In
general, children under age 3 do not benefit from the use of stimulants. Approximately 50% of children aged 3 to 5 years who
are given stimulants benefit from them, and approximately 75%
of the children aged 6 years and older respond positively to medication (5). Although preschool children are less likely to benefit
from stimulant medication and are more likely to exhibit side
effects than older children (26), the use of stimulants in these
children is widespread (8) and potentially beneficial in some
cases (26,27). The most commonly recommended initial and
maximum daily dosages of these medications are presented in
Table 2.
Numerous texts provide comprehensive discussions of treatment side effects (5,8,28). The two most commonly reported
side effects of stimulants are appetite suppression and insomnia.
Safer and Allen (29) reported supression of height and weight
with chronic use of stimulants. However, subsequent research
suggested that such suppression occurs most commonly in doses
above 1 mg/kg/day with methylphenidate hydrochloride and at
half this level with dextroamphetamine sulfate (30). Gross (31)
noted that the suppressive effect is minimal over time and is
often followed by a rebound effect when treatment is stopped. In
a well-controlled study, McNutt and colleagues (32) found no
evidence of suppression in height or weight over one year of
treatment. Thus, as Campbell et al (33) noted, the controversy
on the issue of height and weight suppression as a secondary feature to treatment with stimulants continues. Insomnia occurs
most often when stimulants are given in the late aftemoon. Hyperirritability and emotional lability, other potential side effects,
are especially prominent as the medication wears off or as dosage is increased. These side effects can interfere significantly
with the child's general behavioral, social, and academic performance. They can be misinterpreted as a need for more medication which, if given, only intensifies the negative effects.
There is no evidence that stimulants are addictive or that they
have long-term negative side effects as do the antipsychotic
dmgs (22). Psychotic reactions reportedly occur most often with
dosages within the recommended therapeutic range, but these
reactions have been infrequent (5,34). The physical and/or psychologic side effects of stimulant medication are minimal compared to those of all other psychotropic medications (8,35).
There are potential indirect psychosocial effects of stimulant
medication use. For example, children on medication might assume their behavior is solely a function of the "pill" and hence
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feel no sense of personal responsibility for their behavior. Some
children dislike taking the medication and feel they are "weird."
The child's perceptions, as well as those of his/her parents and
teachers, are important factors to consider when stimulant medication treatment is considered. Whalen and Henker (36) reviewed the psychosocial issues surrounding the use of stimulant
medication with children.
While stimulant medication is a reasonable treatment approach, the conditions under which it should be recommended
need to be identified. Some children with the ADD function well
socially and academically. Should such children be given medication simply to make them less restless and more attentive?
What should be done if parents refuse to give medication to their
child, despite the appropriateness of the diagnosis of ADD? Do
physicians, educators, and mental health professionals have the
right to pressure parents to give their child the medication? Unfortunately, there is no singularly accepted or unambiguous set
of guidelines to answer these questions. Guidelines published
by the Committee on Children with Disabilities/Committee on
Drags (37) describe such issues as choice of medication, dosage, and the importance of altemative or adjunct treatment(s),
but do not provide insight about whether or not to treat the child
with stimulant medication.

Psychological behavior therapy
The efficacy of individual psychotherapy has been questioned
for many childhood disorders (22), and no convincing evidence
exists regarding the utility of such an approach with children
who present with the ADD. Behavior therapy approaches have
not fared much better (38). Educating parents and teachers on
how to manage and help these children to function more appropriately may be far more important.

Outcome
In their review of the outcome of the ADD, Weiss and
Hechtman (3) concluded that: 1) core symptoms (restlessness,
attention difficulties, and impulsivity) tended to persist in adolescence and adulthood, although they may be manifested
somewhat differently and less intensely; 2) a significant percentage (approximately 25%) of adolescents with a history of attention deficit behaviors manifested antisocial behavior; 3) both
children and adolescents with a history of attention deficit behaviors had more problems with self-esteem, social skills, and
impulsivity than control subjects; 4) while symptoms may continue into adulthood, most studies indicated that a substantial
proportion of subjects (30% to 50%) displayed behavior indistinguishable from normal adults; and 5) approximately 20% to
25% of the adults had significant drag and/or alcohol problems
and/or significant antisocial behavior
Outcome is most likely related to the following factors: I) intensity of symptoms, 2) social adaptability, 3) intelligence and
academic achievement levels, 4) stability of the family, 5)
the parents' ability to manage the child's attention deficit behaviors, 6) social/emotional adjustment of the parents, and 7) the
ability of school personnel to manage the child's attention
deficit behaviors.

Henry Ford Hosp Med J—Vol 36, No 4, 1988

Table 2
Medication for Children with the Attention Deficit
Disorder*
Starting
Maximum
Drag
Dose
Dose
Methylphenidate hydrochloride
0.30 mg/kg
I.OO mg/kg
Dextroamphetamine sulfate
0.15 mg/kg
0.50 mg/kg
Pemoline
0.50 mg/kg
2.00 mg/kg
*From Donnelly M. Rapoport JL. Attention deficit disorders. In: Wiener JM. ed. Diagnosis and psychopharmacology of childhood and adolescent disorders. New York: John
Wiley. 1985.
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